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Abstract
Background: Non-human primates are valuable models for the study of insulin resistance and human obesity. In baboons,
insulin sensitivity levels can be evaluated directly with the euglycemic clamp and is highly predicted by adiposity, metabolic
markers of obesity and impaired glucose metabolism (i.e. percent body fat by DXA and HbA1c). However, a simple method to
screen and identify obese insulin resistant baboons for inclusion in interventional studies is not available.
Methods: We studied a population of twenty baboons with the euglycemic clamp technique to characterize a population of
obese nondiabetic, insulin resistant baboons, and used a multivariate linear regression analysis (adjusted for gender) to test
different predictive models of insulin sensitivity (insulin-stimulated glucose uptake = Rd) using abdominal circumference and
fasting plasma insulin. Alternatively, we tested in a separate baboon population (n = 159), a simpler model based on body weight
and fasting plasma glucose to predict the whole-body insulin sensitivity (Rd/SSPI) derived from the clamp.
Results: In the first model, abdominal circumference explained 59% of total insulin mediated glucose uptake (Rd). A second
model, which included fasting plasma insulin (log transformed) and abdominal circumference, explained 64% of Rd. Finally, the
model using body weight and fasting plasma glucose explained 51% of Rd/SSPI. Interestingly, we found that percent body fat was
directly correlated with the adipocyte insulin resistance index (r = 0.755, p < 0.0001).
Conclusion: In baboons, simple morphometric measurements of adiposity/obesity, (i.e. abdominal circumference), plus baseline
markers of glucose/lipid metabolism, (i.e. fasting plasma glucose and insulin) provide a feasible method to screen and identify
overweight/obese insulin resistant baboons for inclusion in interventional studies aimed to study human obesity, insulin
resistance and type 2 diabetes mellitus.
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Non-human primates are valuable models for the study of
human disease, because of their close genetic and physio-
logic similarity to man [1-3]. The baboon (Papio hamadr-
yas) is a long lived primate with an average lifespan of ~25
years that can be maintained in controlled conditions for
generations, in order to evaluate the interaction between
genetic and environmental factors in the pathogenesis of
complex diseases [1,4,5]. Baboons display biochemical
and molecular characteristics of the insulin resistance
(metabolic) syndrome and type 2 diabetes (T2DM), as
they progress from a lean to an obese phenotype and dur-
ing the normal process of aging [5-8]. Not surprisingly,
these primates develop several pathologies similar to
those in man and they have been widely used and estab-
lished as models for osteoporosis, atherosclerosis and
obesity [4,9-11]. Recently, using the hyperinsulinemic
euglycemic clamp technique, we characterized the
baboon as a model of insulin resistance and identified key
biochemical and molecular defects in the insulin signal-
ing cascade in some target tissues (skeletal muscle and
adipose tissue) [12]. Our results demonstrated that insu-
lin resistance is directly related to fat mass, with percent
body fat measured by dual-energy X ray absorptiometry
(DXA) being the best predictor for insulin resistance.
However, in large scale studies, the feasibility of DXA scan
as a screening method to identify insulin resistant
baboons is limited, because it is laborious and expensive.
At our Institution, as part of the routine animal hus-
bandry, all baboons receive a biannual health check.
While sedated for this health check, animals are also
weighted and basic morphometric measurements are
obtained along with a blood chemistry panel for meta-
bolic profiling [4]. We sought to develop a simple screen-
ing strategy to identify lean insulin-sensitive and obese-
insulin resistant baboons for inclusion in genetic, physio-
logic and pharmacologic studies of obesity and insulin
resistance using morphometric and biochemical markers
of adiposity and glucose metabolism. Our results demon-
strate the value of simple morphometric (abdominal cir-
cumference) and metabolic measurements (fasting
plasma glucose and insulin) to predict insulin sensitivity
in this baboon non human primate model.
Methods
Study population and morphometrics
Twenty adult nondiabetic baboons (10 females and 10
males) with varying degrees of adiposity and insulin sen-
sitivity comprised the original study population. For
inclusion, sedated baboons were evaluated with morpho-
metric measurements including weight, crown to heel
length, BMI, abdominal circumference (measured with a
flexible non-stretchable measuring tape at a level midway
between the lower rib margin and iliac crest) and a bio-
chemical panel during the course of a scheduled health
check. Morphometrics and metabolic assessments were
performed during the last scheduled health check for each
baboon. The clinical and biochemical characteristics of
this study population have been published elsewhere
[12].
In addition, we studied a second group of baboons (n =
159) during a scheduled health check. Recorded measure-
ments included body weight, fasting plasma glucose and
insulin concentrations. Only baboons with a stable body
weight over the previous six months, fasting plasma glu-
cose <150 mg/dl and fasting plasma insulin concentra-
tions <100 μU/ml were considered for inclusion. The
purpose of this group was to validate a simpler predictive
model using fasting plasma glucose and body weight
derived from the first group (n = 20).
Assessment of insulin sensitivity and calculations
Under general anesthesia, baboons received a 2-hour 60
mU/m2.min hyperinsulinemic euglycemic clamp after an
overnight fast (~12 hour), as previously described [12,13].
During the steady state of the clamp (90–120 min) at the
prevailing insulin concentrations, the skeletal muscle and
adipose tissue are maximally stimulated, and demon-
strated by an increased activation in key insulin signaling
proteins starting at 30 min after insulin infusion [12].
Fasting plasma glucose (FPG) was measured by the glu-
cose oxidase method (Beckman Glucose Analyzer 2, Beck-
man-Coulter, Fullerton, CA); plasma (FFA) free fatty acids
were measured at baseline and by the end of the clamp
using an enzymatic colorimetric assay (Wako Chemicals
USA). Finally, fasting plasma insulin (FPI) concentration
was determined using a commercial radioimmunoassay
(Diagnostic Products, Los Angeles, CA) at baseline and at
10–15 minutes intervals throughout the euglycemic
clamp. Steady state plasma insulin was calculated as the
mean insulin concentrations from 90 to 120 min. Whole
body insulin sensitivity was calculated as the mean glu-
cose infusion rate during the steady state, reflecting the
insulin-stimulated rate of glucose disposal (Rd). Alterna-
tively, we calculated the whole body insulin sensitivity as
the ratio between the Rd in milligrams of glucose per kg
of lean body mass and SSPI (Rd/SSPI). Using the FPG and
FPI, we also calculated the quantitative insulin sensitivity
check index (QUICKI) as 1/log (FPI) + log (FPG) [14]. The
adipocyte insulin resistance index (AIRI) that estimates
the ability of adipocytes to suppress the rate of lipolysis in
response to insulin was calculated as the fasting FFA con-
centrations multiplied by FPI (AIRI = FFA*FPI). Since
baboons show a marked gender dimorphism in some
morphometric and metabolic parameters, all analyses
were adjusted for gender differences and variables with a
non-normal distribution were log transformed prior to
analysis.Page 2 of 9
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morphometrics and metabolic assessment
In order to determine the predictive value of metabolic
and morphometric measurements, we constructed two
different models using a stepwise linear regression analy-
sis, with Rd as the dependent variable. In the first model
(Model 1), abdominal circumference, adjusted for gender,
was the independent variable. In the second model
(Model 2), we included abdominal circumference and FPI
(log transformed) as the independent variables. Lastly, we
created a model to predict Rd/SSPI (Model 3), by using
fasting plasma glucose concentrations and total body
weight as independent variables. We applied the formula
for the prediction of Rd/SSPI to a second group of
baboons (n = 159), in which body weight was stable over
the previous 6 months, during a bi-annual scheduled
health check that included measurements for body
weight, fasting plasma glucose and insulin concentra-
tions. Only baboons with a fasting plasma glucose <150
mg/dl and fasting plasma insulin concentrations <100
μU/ml were considered for the validation of this predic-
tive analysis model.
Pearson's and/or Spearman partial correlations were cal-
culated as appropriate. We used a step-wise approach to
include significant correlations into the linear regression
models. Statistical analyses were performed using
Statview 5.0 (SAS Institute, Cary, NC) statistical package.
A p value of < 0.05 was considered statistically significant.
Results
Insulin sensitivity and body fat composition measurements
In our study population, the Rd spanned a wide range of
insulin sensitivity. Using a cut-off point for Rd <5 mg/
kg.min to screen for insulin resistant primates we identi-
fied 10 insulin resistant baboons range and 10 insulin
sensitive baboons. In baboons, similar to humans, there
was a marked gender dimorphism in percent body fat,
where females had significantly higher percent body fat
compared to males (12 ± 2 vs. 6 ± 1.5%, p = 0.05).
Morphometrics, markers of adiposity and insulin 
resistance in the adipocyte
In our study population, abdominal circumference corre-
lated directly with the adipocyte insulin resistance index (r
= 0.693, p < 0.02). When percent body fat content was
measured using DXA, it also showed a strong correlation
with the adipocyte insulin resistance index (R = 0.755, p <
0.001) (Table 1), but not with total and lean body mass.
Regression analysis and predictive models of insulin 
sensitivity
In a multivariate model, after adjusting for gender, the
best determinants of insulin sensitivity were fasting
plasma glucose (adjusted R2 = 0.15), insulin concentra-
tions (log transformed, adjusted R2 = 0.32), total body fat
(adjusted R2 = 0.39), percent fat (adjusted R2 = 0.46), and
abdominal circumference (adjusted R2 = 0.59).
In the first model (Model 1), we used abdominal circum-
ference and gender to predict of tissue sensitivity to insu-
lin (Figure 1-A, predicted Rd = -3.618*sex-0.376 *
"Abdominal Circ" + 29.508, with sex = 1 for male, and 0
for females). The explained variability was 59%, with
insulin sensitivity levels negatively correlated with
abdominal circumference (partial R = -0.79, p < 0.0001)
and gender (partial R = -0.55, p < 0.03). The regression
analysis showed a high degree of correlation between the
predicted and measured levels of insulin sensitivity (Fig-
ure 1A, R = 0.796, p < 0.0001). Since the increase in
abdominal circumference is directly correlated with per-
cent body fat and visceral obesity in baboons, this finding
suggests that, similar to humans, a pattern of central adi-
posity predicts the presence of an insulin resistance meta-
bolic syndrome in the baboon.
Table 1: Correlations between the adipocyte insulin resistance index and morphometric markers of adiposity body fat composition 
and biochemical data.
Variable Correlation Coefficient P value
BMI (kg/m2) 0.731 0.001*
Abdominal Circumference (cm) 0.693 0.002*
Percent body fat (%) 0.889 0.001*
FPG (mg/dl) 0.261 0.313
HbA1c (%) 0.257 0.320
Suppression FFA90–120 (%) 0.153 0.558
* = two tailed level of significance < 0.05.Page 3 of 9
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the model. On the other hand, the inclusion of log (FPI)
in the second model (Model 2), overall improved its pre-
dictive power (adjusted R2 = 0.64, predicted Rd = -
4.894*sex-0.309 * "Abdominal Circ" -1.678* log (FPI) +
30.294, with sex = 1 for male, and 0 for females). How-
ever, despite the fact that abdominal circumference (par-
tial R = -0.72, p = 0.001) and gender (partial R = -0.63, p
= 0.007) were strong independent predictors of insulin
sensitivity, the FPI was not independently correlated to Rd
(partial R = -0.42, p = 0.09). The agreement between pre-
dicted and measured levels of insulin sensitivity is shown
in Figure 1B (R = 0.836, p < 0.0001).
In Model 3, we considered weight and fasting plasma glu-
cose as independent variables since these are the routine
measurements collected during biannual health check.
Model 3 also was able to predict well insulin sensitivity
(Predicted Rd/SSPI = 17.18–0.305* Body Weight-
0.056*FPG), explaining 51% of the insulin sensitivity var-
iability as shown in Figure 1C (R = 0.717, p < 0.001).
Linear regression models to predict insulin resistance in adult nondiabetic baboons using (A) abdominal circumference (Model 1), (B) abdominal circumferenc  + log FPI (Model 2), a d (C) body weight + fasti g plasma glucose (Model 3), as independent variablesFigu  1
Linear regression models to predict insulin resistance in adult nondiabetic baboons using (A) abdominal cir-
cumference (Model 1), (B) abdominal circumference + log FPI (Model 2), and (C) body weight + fasting plasma 
glucose (Model 3), as independent variables. FPI = fasting plasma insulin.
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scale, using the abdominal circumference model to pre-
dict insulin sensitivity (Figure 2). According to this model,
an abdominal circumference >55 cm in males and >65 cm
in females is highly predictive for insulin resistance in
baboons.
Body weight and fasting plasma glucose as predictors of 
insulin sensitivity in baboons
Although abdominal circumference was the strongest pre-
dictor of whole body insulin sensitivity, this measurement
was not always readily available in health check records as
a routine screening procedure. Therefore, we sought to
validate Model 3 into a larger population in which
abdominal circumferences were not available. Using this
approach (Model 3 = body weight + FPG), we tested the
predictive model in 159 baboons with a wide range of
weight, fasting glucose and fasting insulin (Table 2). We
stratified the animal population according to quartiles of
predicted insulin sensitivity (Q1 = 38, Q2 = 41, Q3 = 39
and Q4 = 41). We found that the mean predicted Rd/SSPI
was 8-fold higher in the insulin sensitive group compared
to the insulin resistant quartile (Q1 = >8.4 vs. Q4 = <1.1
mg/kgLBM per μU/ml (plasma insulin), p < 0.001). For the
whole population, the 25th percentile was <2.906 vs. 75th
>7.252 mg/kgLBM per μU/ml (plasma insulin). The gender
distribution showed gender dimorphism (males Rd/SSPI
25th = 1.51 vs. 75th = 4.537 mg/kgLBM per μU/ml (plasma
insulin) and females Rd/SSPI 25th = 4.66 vs. 75th = 7.94
mg/kgLBM per μU/ml (plasma insulin).
Body weight and fasting plasma glucose are better 
predictors of peripheral insulin sensitivity in baboons
Although there were clear cut differences in whole body
insulin sensitivity (predicted Rd/SSPI) and a progressive
increase in FPG from the lowest to the highest quartiles
across the study population (Figures 3-A and 3-B), when
we used surrogate indices of insulin sensitivity calculated
during the fasting state (i.e. ln_FPI and QUICKI), no sig-
nificant differences were found between groups (Figures
3-C and 3-D). Of note, the same results were obtained
after gender specific comparison were performed (Figures
3-E and 3-F). This further supports the known limitation
of FPI and QUICKI as surrogate measurements to differen-
tiate peripheral (muscle) from central (liver) insulin
resistance. Therefore, given their nature of steady fasting
state measurements, FPI and QUICKI mainly reflect cen-
tral (liver) insulin resistance [15,16].
Discussion
In the present study, we evaluated the predictive value of
simple markers of adiposity for the presence of insulin
resistance (measured with the gold-standard euglycemic
insulin clamp technique) in a population of adult nondi-
abetic baboons. Our results support the use of abdominal
circumference as a simple and feasible measurement to
predict insulin resistance in these non-human primates.
Our findings are consistent with previous observations
which demonstrated that baboons become insulin resist-
ant as they develop a central obese phenotype [17]. In
fact, it is well known that baboons develop early features
of insulin resistance and metabolic syndrome along with
a high body mass when they are exposed to unnatural
Relationship between abdominal circumference (independent variable) and predicted rate of insulin-stimulat d glucose dis-pos l (Rd)Figur  2
Relationship between abdominal circumference 
(independent variable) and predicted rate of insulin-
stimulated glucose disposal (Rd).
Table 2: Clinical and metabolic characteristics of the baboon 
population (n = 159) used to apply and validate the ISI (Rd/SSPI) 
predictive model, distributed by quartiles.
Variable Q1
(n = 38)
Q2
(n = 41)
Q3
(n = 39)
Q4
(n = 41)
Age (yrs) 20 ± 5 19.8 ± 4 18 ± 5 17.5 ± 5
Weight (kg) 24 ± 9 15 ± 2 26 ± 4 35 ± 6
FPG (mg/dl) 78 ± 12 88 ± 20 89 ± 19 97 ± 20
FPI (mU/ml) 32 ± 6 22 ± 5 37 ± 21 33 ± 6
FFA (mEq/L) 582 ± 60 587 ± 72 635 ± 56 687 ± 61
QUICKI 2.8 ± 1 2.7 ± 1 2.7 ± 1 2.8 ± 1
Values are expressed as mean ± SD. FPG = fasting plasma glucose, FPI 
= fasting plasma insulin, FFA = free fatty acids.
Q1 represents the most insulin sensitive quartile and Q4 represents 
the more insulin resistant quartile, FPG = fasting plasma glucose, FPI = 
fasting plasma insulin, FFA = free fatty acids, QUICKI = quantitative 
insulin sensitivity check index.Page 5 of 9
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Measurements of insulin sensitivity and glucose metabolism in a population of 159 baboons, divided by quartiles of insulin sen-sitivityFigure 3
Measurements of insulin sensitivity and glucose metabolism in a population of 159 baboons, divided by quar-
tiles of insulin sensitivity. (A) Rd/SSPI (B) FPG (C) log Insulin (D) QUICKI (E) Rd/SSPI adjusted for gender (F) QUICKI, 
adjusted for gender. Quartile 1 represents insulin sensitive baboons and Q4 insulin resistant baboons. White bar = male, black 
bar = female. * p < 0.05 vs. Q1 for whole group, # p < 0.05 vs. Q1 in females, ## p < 0.05 vs. Q1 in males.
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fat saturated human food waste in those living close to
touristic facilities) compared to wild baboons subsisting
mainly on forage [18]. During weight gain, baboons accu-
mulate fat in the abdominal area (both visceral and sub-
cutaneous) and the abdominal circumference is
correlated with abdominal fat content and percent body
fat. Although it is known that percent body fat correlates
well with total body weight and abdominal circumference
in both gender, there are not definitive established cut
points for the diagnosis of obesity in baboons [4]. There-
fore, in our study we have included baboons exhibiting a
wide range of adiposity measured by abdominal circum-
ference and percent body fat. Of note, when simple meta-
bolic measurements and insulin sensitivity indices in the
fasting state (such as FPG, FPI and QUICKI) are used in
conjunction with abdominal circumference, the predic-
tive power of the model increases and explains a very large
portion (~70%) of the variation in insulin sensitivity.
Our study has several strengths: (i) the study population
is a well characterized group of baboons from the mor-
phometric, biochemical and molecular standpoint with
clear cut differences between the lean, insulin sensitive
and the obese, insulin resistant baboons; (ii) this nonhu-
man primate model mimics closely findings in humans
that relate the presence of a central obese phenotype with
impaired glucose metabolism and insulin resistance, indi-
cating the presence of the insulin resistance (metabolic)
syndrome equivalent in the baboon [19-23]. One poten-
tial weakness of our analyses is that we studied a relative
small number of primates with the euglycemic clamp.
However, we included baboons of both genders with a
wide spectrum of insulin sensitivity, abdominal circum-
ference and percent body fat. Moreover, we were able to
validate a predictive model of insulin resistance based on
total body weight and fasting glucose, which are useful
surrogates to abdominal circumference when this is not
readily available. Our findings are in agreement with
other report and covered the range from the lean, insulin-
sensitive to overweight/obese, insulin-resistant baboons
[4,5]. Our findings also support the fact that insulin resist-
ance is progressive, as baboons evolve from a lean to an
overweight/obese phenotype. The insulin resistance is evi-
dent not only at the glucose uptake level in skeletal mus-
cle, but also in the adipose tissue, as is demonstrated by
the lack of suppression of FFA concentrations in the pres-
ence of high insulin levels in the baboons with the highest
percent body fat, expressed as the adipocyte insulin resist-
ance index. The estimation of adipocyte insulin resistance
index provides some insight into the dysregulation of adi-
pocyte biology present in obesity and the metabolic syn-
drome Therefore, the measurements of FFA and insulin
could be of help to identify those baboons likely to have
not only physical, but also metabolic and molecular fea-
tures of the insulin resistant phenotype.
Although our results were obtained in baboons, they are
likely to be applicable to other non-human primates,
since the array of metabolic abnormalities associated with
an obese phenotype is well documented across primate
species [8,24-27]. Moreover, the use of morphometrics,
specifically abdominal circumference is also very likely to
predict insulin resistance when other methods different
from the euglycemic clamp are used to quantitate insulin
sensitivity (i.e. minimal model assessment from oral or IV
glucose tolerance test), given the documented correlation
between these techniques [28].
Our results are in agreement with several larger human
cohorts demonstrating the predictive power of abdominal
and trunk fat deposits to predict the presence of different
traits of the insulin resistance metabolic syndrome and its
co morbidities [21,29-31]. Although the use of abdomi-
nal circumference is a simple and feasible measurement
that provides useful information about the insulin sensi-
tivity and overall the metabolic status in baboons, it is not
always readily available for screening purposes in primate
studies. For this reason, we developed a model that
included variables generally available and routinely col-
lected as part of the semi-annual scheduled health checks
at our institution. While the model considering body
weight and fasting plasma glucose (Model 3) was not as
powerful as abdominal circumference to explain the vari-
ability in insulin sensitivity, it was able to dissect clear cut
differences in insulin sensitivity across the study group.
These data further support the value of this baboon non-
human primate as a model for the study of obesity and
metabolic diseases in humans. Based on our results, we
propose an algorithm for screenings of primates in order
to identify those who are likely to present features of obes-
ity or insulin resistance for inclusion in research studies
(Figure 4). Since genetic, nutritional and environmental
factors seem to play a complex integrated role in the
pathogenesis of obesity and its associated traits, we
strongly believe these findings could be applied to both
wild and captive baboons.
In summary, abdominal circumference is a major deter-
minant of insulin sensitivity in both male and female
baboons, and its association with fasting measurements
of glucose metabolism and insulin sensitivity, i.e. FPI and
FPG, provide a useful instrument to screen primates to
identify insulin sensitive and insulin resistant for inclu-
sion in large scale protocols designed to examine the
effects of dietary and pharmacological interventions in the
study of obesity, insulin resistance and type 2 diabetes in
humans.Page 7 of 9
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